[#item_full_content] A federal appeals court has laid out the schedule for a lawsuit brought by a coalition of anti-marijuana groups and a cannabis-focused biopharmaceutical corporation that are challenging the Trump administration’s initiative to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. In May, Judge Trevor N. McFadden dismissed the challenge
Read More